Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Jiangsu Simcere Pharmaceutical identifies new PRMT5 inhibitors

June 1, 2021

Nerviano Medical Sciences patents IDH inhibitors

June 1, 2021

Nanjing Ruijie Pharma divulges ACC inhibitors

June 1, 2021

AbbVie initiates first-in-human study of ABBV-623 and ABBV-992

June 1, 2021

Bacteriophage delivery of TNF-alpha gene therapy suppresses chondrosarcoma tumors in vivo

June 1, 2021

Disulfiram/copper gluconate studied in phase I for treatment-refractory multiple myeloma

May 31, 2021

RNF6 and SF3B2 are novel therapeutic targets in colorectal cancer

May 31, 2021

BPRCX-807 demonstrates promising activity in models of HCC

May 31, 2021

Nanjing Sanhome Pharmaceutical synthesizes PTPN11 inhibitors

May 31, 2021

Guangzhou Henovcom Bioscience patents ENPP2 inhibitors

May 31, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...